Physician

Allison Pierce, M.D.

According to 2025 Medicare claims, Allison Pierce, M.D. (NPI: 1316365455) practices dermatology in the Kingsport-Bristol, TN-VA market, with the plurality of this provider's patient population coming from Sullivan, TN. This provider's primary affiliated billing organization is DERMATOLOGY ASSOCIATES, P.C. (NPI: 1487695862; TIN: 62-1013399) and primary practice location at 37660-2360.

Pierce's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,009 traditional Medicare patients, billed 5,505 HCPCS/CPT codes, and received $230,308 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 2,116 prescription claims across 867 beneficiaries totaling $1,196,649 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $57,431 to $230,308. Similarly, Part D prescription costs have risen steadily, from $31,307 to $1,196,649. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$115K$230K2018 Medicare payment: $57,431 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $164,246 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $154,375 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $209,407 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $211,032 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $204,587 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $230,308 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20184091,408$57,431
20198994,850$164,246
20208094,312$154,375
20219795,277$209,407
20221,0095,260$211,032
20239444,894$204,587
20241,0095,505$230,308

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$598K$1.2M2015 Drug cost: $31,307 (USD; Tot_Drug_Cst)2016 Drug cost: $269,789 (USD; Tot_Drug_Cst)2017 Drug cost: $190,101 (USD; Tot_Drug_Cst)2018 Drug cost: $103,223 (USD; Tot_Drug_Cst)2019 Drug cost: $300,809 (USD; Tot_Drug_Cst)2020 Drug cost: $579,151 (USD; Tot_Drug_Cst)2021 Drug cost: $656,758 (USD; Tot_Drug_Cst)2022 Drug cost: $740,735 (USD; Tot_Drug_Cst)2023 Drug cost: $650,181 (USD; Tot_Drug_Cst)2024 Drug cost: $1,196,649 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201592180$31,307
2016163471$269,789
2017142381$190,101
2018291549$103,223
20196241,445$300,809
20206821,561$579,151
20218051,889$656,758
20227511,751$740,735
20237781,788$650,181
20248672,116$1,196,649

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth253282$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more656853$58
17000Destruction of precancer skin growth, 1 growth342439$33
88305Pathology examination of tissue using a microscope, intermediate complexity395730$26
17003Destruction of precancer skin growth, 2-14 growths2551,217$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa12784$254,641
Dupixent PenDupilumab33871$127,292
Cosentyx Sensoready (2 Pens)Secukinumab12336$89,870
XolairOmalizumab11308$30,344
FluorouracilFluorouracil1715,117$14,161

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$25Tarsus Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Allison Pierce, M.D.?

Tedicare shows public-source Medicare data for Allison Pierce, M.D. (NPI 1316365455), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allison Pierce, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Allison Pierce, M.D.?

Allison Pierce, M.D. is linked to DERMATOLOGY ASSOCIATES, P.C. (billing NPI 1487695862) in the available physician profile data.

Does Allison Pierce, M.D. have Open Payments data?

Allison Pierce, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.